The feasibility of mindfulness-based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial.
Addiction April 30, 2026 DOI: 10.1111/add.70441 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA pilot randomized controlled trial tested the feasibility of mindfulness-based relapse prevention (MBRP) for Chinese adults with substance use disorders involving illicit drugs. Participants were assigned to MBRP or a control condition. The study found that MBRP was feasible and acceptable in this population, with high attendance and satisfaction rates. The intervention suggests potential benefits for reducing relapse risk, though the pilot design limits firm conclusions. No null or negative findings were reported.
Study at a glance
| Characteristics | Pilot randomized controlled trial Peer reviewed |
|---|---|
| Population | Chinese adults with substance use disorders (illicit drugs) |
| Intervention | Mindfulness-based relapse prevention |
| Key finding | Mindfulness-based relapse prevention was feasible and acceptable for Chinese adults with substance use disorders involving illicit drugs. |
Abstract
The feasibility of mindfulness-based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial.